Sector Gamma As Incyte Corp Transaction History

Sector Gamma As

$297 Million
Q1 2025

A detailed history of Sector Gamma As transactions in Incyte Corp stock. As of the latest transaction made, Sector Gamma As holds 159,000 shares of INCY stock, worth $12.3 Million. This represents 3.24% of its overall portfolio holdings.

Number of Shares

159,000

Previous 197,400 19.45%

Holding current value

$12.3 Million

Previous $13.6 Million 29.39%

% of portfolio

3.24%

Previous 4.95%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$60.0 - $75.26 $2.3 Million - $2.89 Million	-38,400 Reduced 19.45%	159,000 $9.63 Million
Q4 2024 Feb 11, 2025	SELL	$65.08 - $83.38 $4.01 Million - $5.14 Million	-61,600 Reduced 23.78%	197,400 $13.6 Million
Q3 2024 Nov 13, 2024	BUY	$57.33 - $68.61 $3.19 Million - $3.82 Million	55,624 Added 27.35%	259,000 $17.1 Million
Q2 2024 Aug 09, 2024	SELL	$51.18 - $63.75 $3.15 Million - $3.92 Million	-61,519 Reduced 23.22%	203,376 $12.3 Million
Q1 2024 May 08, 2024	SELL	$56.55 - $66.59 $7.57 Million - $8.91 Million	-133,804 Reduced 33.56%	264,895 $15.1 Million
Q4 2023 Feb 05, 2024	SELL	$52.16 - $64.19 $1.77 Million - $2.17 Million	-33,846 Reduced 7.82%	398,699 $25 Million
Q3 2023 Nov 06, 2023	BUY	$57.77 - $65.93 $2.02 Million - $2.31 Million	35,013 Added 8.81%	432,545 $25 Million
Q2 2023 Aug 09, 2023	SELL	$60.95 - $75.51 $2.12 Million - $2.62 Million	-34,703 Reduced 8.03%	397,532 $24.7 Million
Q1 2023 May 12, 2023	BUY	$70.23 - $86.01 $1.46 Million - $1.78 Million	20,748 Added 5.04%	432,235 $31.2 Million
Q4 2022 Feb 07, 2023	SELL	$67.18 - $84.11 $490,884 - $614,591	-7,307 Reduced 1.74%	411,487 $33.1 Million
Q3 2022 Nov 09, 2022	SELL	$66.18 - $82.86 $2.69 Million - $3.37 Million	-40,635 Reduced 8.84%	418,794 $27.9 Million
Q2 2022 Aug 05, 2022	BUY	$66.18 - $83.18 $1.15 Million - $1.45 Million	17,417 Added 3.94%	459,429 $34.9 Million
Q1 2022 May 06, 2022	BUY	$66.02 - $79.71 $4.17 Million - $5.03 Million	63,160 Added 16.67%	442,012 $35.1 Million
Q4 2021 Feb 08, 2022	BUY	$63.34 - $74.11 $4.82 Million - $5.64 Million	76,113 Added 25.14%	378,852 $27.8 Million
Q3 2021 Oct 29, 2021	BUY	$68.67 - $84.02 $1.28 Million - $1.56 Million	18,594 Added 6.54%	302,739 $20.8 Million
Q2 2021 Aug 04, 2021	SELL	$79.87 - $87.53 $4.55 Million - $4.98 Million	-56,906 Reduced 16.69%	284,145 $23.9 Million
Q1 2021 May 10, 2021	SELL	$76.02 - $100.5 $804,139 - $1.06 Million	-10,578 Reduced 3.01%	341,051 $27.7 Million
Q4 2020 Feb 10, 2021	BUY	$80.74 - $97.7 $5.39 Million - $6.52 Million	66,725 Added 23.42%	351,629 $30.6 Million
Q3 2020 Nov 09, 2020	BUY	$85.07 - $109.69 $758,569 - $978,105	8,917 Added 3.23%	284,904 $25.6 Million
Q2 2020 Aug 07, 2020	SELL	$74.18 - $108.93 $13.1 Million - $19.2 Million	-176,596 Reduced 39.02%	275,987 $28.7 Million
Q1 2020 May 11, 2020	BUY	$63.18 - $85.97 $10.7 Million - $14.6 Million	170,041 Added 60.18%	452,583 $33.1 Million
Q4 2019 Feb 12, 2020	SELL	$73.04 - $95.72 $4.63 Million - $6.06 Million	-63,351 Reduced 18.32%	282,542 $24.7 Million
Q3 2019 Nov 05, 2019	BUY	$72.82 - $86.52 $2.33 Million - $2.77 Million	32,000 Added 10.19%	345,893 $25.7 Million
Q2 2019 Jul 31, 2019	BUY	$73.52 - $88.7 $3.87 Million - $4.67 Million	52,600 Added 20.13%	313,893 $26.7 Million
Q1 2019 May 13, 2019	SELL	$63.56 - $88.17 $4.78 Million - $6.63 Million	-75,151 Reduced 22.34%	261,293 $22.5 Million
Q4 2018 Feb 12, 2019	BUY	$58.5 - $69.94 $7.18 Million - $8.58 Million	122,680 Added 57.39%	336,444 $21.4 Million
Q3 2018 Nov 15, 2018	BUY	$61.75 - $74.23 $5.77 Million - $6.94 Million	93,507 Added 77.76%	213,764 $14.8 Million
Q3 2018 Nov 08, 2018	BUY	$61.75 - $74.23 $7.43 Million - $8.93 Million	120,257 New	120,257 $8.31 Million

Others Institutions Holding INCY

# of Institutions

704

Shares Held

195M

Call Options Held

564K

Put Options Held

317K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $17.2B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sector Gamma As, based on Form 13F filings with the SEC.

News

Stay updated on Sector Gamma As with notifications on news.

Account